Esperion Therapeutics, Inc. (ESPR) has a consensus analyst rating of Hold, based on 25 analysts covering the stock. Of those, 10 recommend buying, 13 recommend holding, and 2 recommend selling.
The analyst consensus price target for ESPR is $9.00, representing a +339.0% upside from the current price of $2.05. Price targets range from a low of $9.00 to a high of $9.00.
